|
|
||||||||

* University of Minnesota Cancer Center and Department of Pediatrics, Division of Bone Marrow Transplantation, Minneapolis, MN 55455; and
Department of Immunology, St. Jude Childrens Research Hospital, Memphis, TN 38105
CD4+CD25+ regulatory T cells (Tregs) play an essential role in controlling autoimmunity and allograft rejection. Several ex vivo activation and expansion protocols have been developed to amplify cell numbers and suppressor function of murine and human Tregs. We demonstrate in this study that ex vivo activation and expansion of murine Tregs resulted in an enrichment of a CD4low/negCD25+ T cell population that was more than 20-fold more potent than expanded conventional Tregs in suppressing an in vitro CD4+CD25– T cell response to allo-Ag. The generation of CD4low/negCD25+ T cells was independent of the presence of Tregs in the culture, and suppressor function was acquired only after activation and expansion. CD4low/negCD25+ T cells expressed either an
β or 
TCR, had an activated phenotype, and did not express the transcription factor FoxP3. Despite expressing the cell surface Ags lymphocyte activation gene-3 (CD223) and CD103, neither was essential for suppressor cell function. Suppression by CD4low/negCD25+ T cells was prevented by a semipermeable membrane and was independent of IL-10 and TGF-β. In summary, we describe in this study CD4low/negCD25+ FoxP3neg T cells with highly potent suppressor cell function derived from cultures of an enriched population of CD4+CD25+ T cells that may contribute to the suppressor activity of ex vivo expanded bone fide Tregs.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported by National Institutes of Health Grants P01 AI056299, R01 AI034495, and R37 HL56067 and the Childrens Cancer Research Fund (to C.V. and B.R.B.).
2 Address correspondence and reprint requests to Dr. Bruce R. Blazar, University of Minnesota, 460F CCRB, 425 East River Road, Minneapolis, MN 55455. E-mail address: blaza001{at}umn.edu
3 Abbreviations used in this paper: Treg, CD4+CD25+ regulatory T cell; DN, double negative; GVHD, graft-vs-host disease; LAG-3, lymphocyte activation gene-3; neg, negative; wt, wild type.
Related articles in The JI:
This article has been cited by other articles:
![]() |
S. Sakaguchi, K. Wing, Y. Onishi, P. Prieto-Martin, and T. Yamaguchi Regulatory T cells: how do they suppress immune responses? Int. Immunol., October 1, 2009; 21(10): 1105 - 1111. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |